These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32980446)

  • 21. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
    Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
    Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and characterization of a recombinant yellow fever virus stably expressing Gaussia luciferase.
    Kassar TC; Magalhães T; S JVJ; Carvalho AGO; Silva ANMRD; Queiroz SRA; Bertani GR; Gil LHVG
    An Acad Bras Cienc; 2017; 89(3 Suppl):2119-2130. PubMed ID: 28746549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
    Zandi K; Amblard F; Amichai S; Bassit L; Tao S; Jiang Y; Zhou L; Ollinger Russell O; Mengshetti S; Schinazi RF
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview on small molecules acting as broad-spectrum agents for yellow fever infection.
    Desantis J; Felicetti T; Cannalire R
    Expert Opin Drug Discov; 2022 Jul; 17(7):755-773. PubMed ID: 35638299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response.
    Gao Z; Zhang X; Zhang L; Wu S; Ma J; Wang F; Zhou Y; Dai X; Bullitt E; Du Y; Guo JT; Chang J
    PLoS Pathog; 2022 Jan; 18(1):e1010271. PubMed ID: 35061864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.
    Kaptein SJ; De Burghgraeve T; Froeyen M; Pastorino B; Alen MM; Mondotte JA; Herdewijn P; Jacobs M; de Lamballerie X; Schols D; Gamarnik AV; Sztaricskai F; Neyts J
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5269-80. PubMed ID: 20837762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes.
    McElroy KL; Tsetsarkin KA; Vanlandingham DL; Higgs S
    J Gen Virol; 2005 Jun; 86(Pt 6):1747-1751. PubMed ID: 15914853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.
    Ren H; Wang J; Tang H; Qian X; Xia B; Luo Z; Xu Z; Qi Z; Zhao P
    Antiviral Res; 2023 Nov; 219():105737. PubMed ID: 37879570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
    Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
    J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel reverse genetics of genotype I and III Japanese encephalitis viruses assembled through transformation associated recombination in yeast: The reporter viruses expressing a green fluorescent protein for the antiviral screening assay.
    Li C; Chen X; Zhou Y; Hu J; Wang X; Li Y
    Antiviral Res; 2022 Jan; 197():105233. PubMed ID: 34973281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
    Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
    Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus.
    Kwallah Ao; Inoue S; Muigai AW; Kubo T; Sang R; Morita K; Mwau M
    J Virol Methods; 2013 Oct; 193(1):23-7. PubMed ID: 23692685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of NS5 Protein in Determination of Host Cell Range for Yellow Fever Virus.
    Laurent-Rolle M; Morrison J
    DNA Cell Biol; 2019 Dec; 38(12):1414-1417. PubMed ID: 31633391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).
    Ono L; Wollinger W; Rocco IM; Coimbra TL; Gorin PA; Sierakowski MR
    Antiviral Res; 2003 Nov; 60(3):201-8. PubMed ID: 14638396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internally Controlled, Multiplex Real-Time Reverse Transcription PCR for Dengue Virus and Yellow Fever Virus Detection.
    Rojas A; Diagne CT; Stittleburg VD; Mohamed-Hadley A; de Guillén YA; Balmaseda A; Faye O; Faye O; Sall AA; Harris E; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2018 Jun; 98(6):1833-1836. PubMed ID: 29611509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus.
    Saudi M; Zmurko J; Kaptein S; Rozenski J; Gadakh B; Chaltin P; Marchand A; Neyts J; Van Aerschot A
    Eur J Med Chem; 2016 Oct; 121():158-168. PubMed ID: 27240271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservation of the pentanucleotide motif at the top of the yellow fever virus 17D 3' stem-loop structure is not required for replication.
    Silva PAGC; Molenkamp R; Dalebout TJ; Charlier N; Neyts JH; Spaan WJM; Bredenbeek PJ
    J Gen Virol; 2007 Jun; 88(Pt 6):1738-1747. PubMed ID: 17485534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and applications of yellow fever virus replicons.
    Jones CT; Patkar CG; Kuhn RJ
    Virology; 2005 Jan; 331(2):247-59. PubMed ID: 15629769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.